Nilo B. Cater

Lipids, Apolipoproteins, and Their Ratios in Relation to Cardiovascular Events With Statin Treatment

John J.P. Kastelein, Wim A. van der Steeg, Ingar Holme et al. · Circulation · 2008 · 472 citations

Medicine, Pharmacology, Pharmacotherapy +17

Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease

Francesco Cosentino, Christopher P. Cannon, David Z.I. Cherney et al. · Circulation · 2020 · 241 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

Incremental reduction of serum total cholesterol and low-density lipoprotein cholesterol with the addition of plant stanol ester-containing spread to statin therapy

Steven N. Blair, David M. Capuzzi, Sidney O. Gottlieb et al. · The American Journal of Cardiology · 2000 · 237 citations

Pharmacy, Pharmacotherapy, Cardiovascular Pharmacotherapy +11

Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial

Michael D. Ezekowitz, Charles V. Pollack, Jonathan L. Halperin et al. · European Heart Journal · 2018 · 172 citations · Full text

Medicine, Cardiology, Pharmacology +17

Effects of adding fenofibrate (200 mg/day) to simvastatin (10 mg/day) in patients with combined hyperlipidemia and metabolic syndrome

Gloria Lena Vega, Patrick T.S, Nilo B. Cater et al. · The American Journal of Cardiology · 2003 · 151 citations

Medicine, Pharmacology, Pharmacotherapy +11